Generic Biosimilar Medicines Association

Making Medicines Affordable

  • Home
  • About GBMA
    • Contact us
    • GBMA Members
    • Guiding principles
    • Code of Practice
      • Code Complaint Committee
      • Event Reporting
        • Educational Events
        • Non-Price Benefit Reports
      • Annual Review
        • 2011
        • 2012
        • 2013
        • 2014
        • 2015
        • 2016
        • 2017
        • 2018
        • 2019
        • 2020
      • Lodging a complaint
    • Media Enquiries
    • Our Objectives
    • Links
  • Advocacy
    • Extended Strategic Agreement
    • Generic Medicines Working Group (GMWG)
    • Submissions
  • Generics
    • Facts and Fallacies
    • Key Figures on Generic Medicines
    • What is a Generic Medicine?
    • Bioequivalence Explained
  • Biosimilars
    • IGBA Global Biosimilars Week
    • GBMA Position on Biosimilars
      • Impact of Biosimilars
      • Switching
      • Pharmacy Substitution
      • Regulation
      • Awareness and Uptake
      • Naming
    • Key Figures on Biosimilars
  • Topics
    • IGBA
    • Price Disclosure
    • Intellectual Property
    • International Trade Agreements
  • News
    • News 2021
    • News 2020
    • News 2019
    • News 2018
    • News 2017
    • News 2016
    • News 2015
    • News 2014
  • GBMA Education
  • COVID-19 Virus
    • COVID-19 Virus: The Facts
You are here: Home / About GBMA / Guiding principles

Guiding principles

The guiding principles of the members of GBMA are:

  • To support the long term sustainability of the PBS by ensuring the timely and cost effective provision of generic and biosimilar medicines to consumers.
  • To support the quality use of medicines (QUM) in partnership with other stakeholders.
  • To support the development of policies that facilitate timely access to generic and biosimilar medicines for all Australians.
  • To support the development of policies that promote the continued viability of a local manufacturing base for generic and biosimilar medicines (for domestic and export markets).
  • To encourage a high level of awareness and general knowledge of the safety, efficacy and appropriate interchangeability of generic medicines amongst healthcare professionals, Government and consumers.
  • To support balanced intellectual property rights in the pharmaceutical sector that enable timely, cost effective access to generic and biosimilar medicines.
  • To enhance the accountability of Members by establishing a complaints handling mechanism that is both readily accessible and transparent.

Our Members

Juno
Juno
Sandoz logo
Sandoz logo
Viatris
Viatris
Arrow logo
Arrow logo
apotex
apotex
Celltrion Healthcare
Celltrion Healthcare
Fresnius Kabi
Fresnius Kabi
Fresnius Kabi
generic_partners
generic_partners
southern_cross
southern_cross
commercial_eyes
commercial_eyes
sinapse
sinapse

Generic Medicines: The Facts

Generic Medicines Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

Biosimilars

https://youtu.be/sBDur7xa084   Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Patients and economy to benefit from ‘medicine manufacturing’ roadmap

March 2, 2021

2 March 2021 Canberra, ACT Australia’s peak body for affordable medicines, today welcomed the Government’s launch of … More...

Active Ingredient Prescribing – a game changer for patients: Prescription reforms to further support patient safety

February 1, 2021

1 February 2021 Canberra, ACT Canberra: Australia’s patients will be the … More...

Announcement of Independent Chair

December 9, 2020

9 December 2020 Canberra, ACT Global health policy powerhouse, Jane Halton … More…

© 2021 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us